Allan M. Brandt

Brandt has been elected to the Institute of Medicine of the National Academy of Sciences and the American Academy of Arts and Sciences. His recent work is focused on the impact of stigma on patients and health outcomes. He is also the co-creator and instructor of the Harvard undergraduate course “Confronting COVID-19: Science, History, Policy.”

Dr. Brandt has been an active member of HGHI’s Steering Committee for many years, and he has a deep interest in global health. As the Interim Director, Brandt will ensure that HGHI continues to be a place where the diverse resources of Harvard are brought together to address critical health issues.

Dr. Katz, the Associate Faculty Director at HGHI, serves as an Associate Physician in the Department of Medicine at Brigham and Women’s Hospital and is a research scientist at the Center for Global Health at Massachusetts General Hospital. Her research over the past decade has focused on the social determinants of health-seeking behavior among people living with HIV in sub-Saharan Africa, with the goal of developing sustainable, socio-behavioral interventions aimed at improving care for the most under-served.

She is trained in Infectious Diseases and received her MD from the University of California at San Francisco and trained in Internal Medicine at Brigham and Women’s Hospital, and in Infectious Diseases at Beth Israel Deaconess Medical Center. She completed a fellowship in Global Women’s Health at Brigham and Women’s Hospital and has been on staff there since 2009.

She has been consistently funded as a Principal Investigator through the National Institutes of Health since 2012 and has served as an Editorial Fellow and a National Correspondent for the New England Journal of Medicine.